We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Physician Groups Turn to Congress to Prevent CMS’ Biosimilar Coding
Physician Groups Turn to Congress to Prevent CMS’ Biosimilar Coding
Physician groups frustrated with federal plans to pair different biosimilar drugs together for billing and reimbursement purposes are turning to Congress for help.